Skip to main content
Livermore
Livermore
ZHEN

Millennium Management LLC

SEC CIK
0001273087
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Millennium Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of APLS by Millennium Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−2,256,802−100.0%Sold outHolders
Q1 20262,256,802$90.8M0.1%+1,310,343+138.4%AddedHolders
Q4 2025946,459$23.8M<0.1%−397,267−29.6%ReducedHolders
Q3 20251,343,726$30.4M<0.1%+1,141,274+563.7%AddedHolders
Q2 2025202,452$3.50M<0.1%−249,521−55.2%ReducedHolders
Q1 2025451,973$9.88M<0.1%−123,517−21.5%ReducedHolders
Q4 2024575,490$18.4M<0.1%+498,104+643.7%AddedHolders
Q3 202477,386$2.23M<0.1%−128,525−62.4%ReducedHolders
Q2 2024205,911$7.90M<0.1%−579,485−73.8%ReducedHolders
Q1 2024785,396$46.2M<0.1%+772,869+6,169.6%AddedHolders
Q4 202312,527$749.9K<0.1%−32,602−72.2%ReducedHolders
Q3 202345,129$1.72M<0.1%−873,682−95.1%ReducedHolders
Q2 2023918,811$83.7M0.1%+370,610+67.6%AddedHolders
Q1 2023548,201$36.2M<0.1%+528,565+2,691.8%AddedHolders
Q4 202219,636$1.01M<0.1%−238,233−92.4%ReducedHolders
Q3 2022257,869$17.6M<0.1%+257,869NewHolders
Q2 20220$00.0%−60,505−100.0%Sold outHolders
Q1 202260,505$3.07M<0.1%−251,497−80.6%ReducedHolders
Q4 2021312,002$14.8M<0.1%−93,380−23.0%ReducedHolders
Q3 2021405,382$13.4M<0.1%+405,382NewHolders
Q2 20210$00.0%−158,571−100.0%Sold outHolders
Q1 2021158,571$6.80M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.